Unknown

Dataset Information

Somatostatin and Astroglial Involvement in the Human Limbic System in Alzheimer's Disease.


ABSTRACT: Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the elderly. Progressive accumulation of insoluble isoforms of amyloid-β peptide (Aβ) and tau protein are the major neuropathologic hallmarks, and the loss of cholinergic pathways underlies cognitive deficits in patients. Recently, glial involvement has gained interest regarding its effect on preservation and impairment of brain integrity. The limbic system, including temporal lobe regions and the olfactory bulb, is particularly affected in the early stages. In the early 1980s, the reduced expression of the somatostatin neuropeptide was described in AD. However, over the last three decades, research on somatostatin in Alzheimer's disease has been scarce in humans. Therefore, the aim of this study was to stereologic

SUBMITTER: Gonzalez-Rodriguez M 

PROVIDER: S-EPMC8395127 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature